Actualités Amryt Pharma Plc - AMYT | Actions London Stock Exchange

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

IN BRIEF: Amryt Pharma delists from AIM as trading shifts to New York

- Dublin, Ireland and Boston, Massachusetts-based biopharmaceutical firm focused on rare diseases - Shares delisted fr ...

FTSE Russell Amryt Pharma

FTSE Russell 06 January 2022 Amryt Pharma (UK): Constituent Deletion Changes in FTSE UK Index Series 06 January 2022 Subject to the expected...

Amryt Pharma plc Key Dates For Aim Delisting

T Amryt Pharma plc - Key Dates for AIM Delisting DUBLIN, Ireland, and Boston MA, January 6, 2022, Amryt Pharma plc (Nasdaq: AMYT, AIM: AMYT...

Amryt Pharma plc The Lancet Diabetes & Endocrinology Publishes Positive Results For The Mpowered Phase 3 Trial For Mycapssa(R) (oral octreotide) In Acromegaly Patients

T The Lancet Diabetes & Endocrinology Publishes Positive Results for the MPOWERED Phase 3 Trial for Mycapssa(R) (oral octreotide) in...

Amryt Pharma plc Total Voting Rights

T Total Voting Rights DUBLIN, Ireland, and Boston MA, January 4, 2022, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage...

Amryt Pharma plc Total Voting Rights

T Total Voting Rights DUBLIN, Ireland, and Boston MA, December 1, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage...

Amryt Pharma plc Director/Pdmr Shareholding

T Amryt Pharma plc Director/PDMR Shareholding The following notification is made in accordance with the requirements of the EU Market Abuse...

Amryt Pharma plc Amryt Provides Update On Regulatory Review Process For Oleogel-S10

T Amryt Provides Update on Regulatory Review Process for Oleogel-S10 FDA PDUFA goal date extended by three months to February 28, 2022 EMA CHMP...

Amryt Pharma plc Amryt Announces The Cancellation Of Admission Of Its Ordinary Shares To Trading On Aim

T THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) NO. 596/2014 WHICH FORMS PART OF...

TRADING UPDATES: Shepherd Neame losses cut; Beximco to sell Covid pill

The following is a round-up of updates by London-listed companies not separately reported by Alliance News: --------- ...

Amryt Pharma plc Amryt Reports Strong Q3 2021 Results

T Amryt Reports Strong Q3 2021 Results 14.6% YoY revenue growth in Q3 to $56.5M 21.5% growth in metreleptin revenues YoY to $36.3M in Q3; 51.6...

Amryt Pharma plc Total Voting Rights

T Total Voting Rights DUBLIN, Ireland, and Boston MA, November 1, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage...

Amryt Pharma plc Amryt To Report Q3 2021 Results And Host Conference Call & Webcast On November 3

T Amryt to Report Q3 2021 Results and Host Conference Call & Webcast on November 3 DUBLIN, Ireland, and Boston MA, October 20, 2021, Amryt...

Amryt Pharma plc Amryt Announces New Patents For Oleogel-S10 And Mycapssa(R)

T Amryt Announces New Patents for Oleogel-S10 and Mycapssa(R) DUBLIN, Ireland, and Boston MA, October 19, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a...

Amryt Pharma plc Total Voting Rights

T Total Voting Rights DUBLIN, Ireland, and Boston MA, October 1, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Amryt Pharma Plc (AMYT)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

AMYT Actualités

IN BRIEF: Amryt Pharma delists from AIM as trading shifts to New York

FTSE Russell Amryt Pharma

Amryt Pharma plc Key Dates For Aim Delisting

Amryt Pharma plc The Lancet Diabetes & Endocrinology Publishes Positive Results For The Mpowered Phase 3 Trial For Mycapssa(R) (oral octreotide) In Acromegaly Patients

Amryt Pharma plc Total Voting Rights

Amryt Pharma plc Total Voting Rights

Amryt Pharma plc Director/Pdmr Shareholding

Amryt Pharma plc Amryt Provides Update On Regulatory Review Process For Oleogel-S10

Amryt Pharma plc Amryt Announces The Cancellation Of Admission Of Its Ordinary Shares To Trading On Aim

TRADING UPDATES: Shepherd Neame losses cut; Beximco to sell Covid pill

Amryt Pharma plc Amryt Reports Strong Q3 2021 Results

Amryt Pharma plc Total Voting Rights

Amryt Pharma plc Amryt To Report Q3 2021 Results And Host Conference Call & Webcast On November 3

Amryt Pharma plc Amryt Announces New Patents For Oleogel-S10 And Mycapssa(R)

Amryt Pharma plc Total Voting Rights

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Amryt Pharma Plc (AMYT) Actualités

Amryt Pharma Plc (AMYT)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

AMYT Actualités

IN BRIEF: Amryt Pharma delists from AIM as trading shifts to New York

FTSE Russell Amryt Pharma

Amryt Pharma plc Key Dates For Aim Delisting

Amryt Pharma plc The Lancet Diabetes & Endocrinology Publishes Positive Results For The Mpowered Phase 3 Trial For Mycapssa(R) (oral octreotide) In Acromegaly Patients

Amryt Pharma plc Total Voting Rights

Amryt Pharma plc Total Voting Rights

Amryt Pharma plc Director/Pdmr Shareholding

Amryt Pharma plc Amryt Provides Update On Regulatory Review Process For Oleogel-S10

Amryt Pharma plc Amryt Announces The Cancellation Of Admission Of Its Ordinary Shares To Trading On Aim

TRADING UPDATES: Shepherd Neame losses cut; Beximco to sell Covid pill

Amryt Pharma plc Amryt Reports Strong Q3 2021 Results

Amryt Pharma plc Total Voting Rights

Amryt Pharma plc Amryt To Report Q3 2021 Results And Host Conference Call & Webcast On November 3

Amryt Pharma plc Amryt Announces New Patents For Oleogel-S10 And Mycapssa(R)

Amryt Pharma plc Total Voting Rights

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités